nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP3A4—Temozolomide—melanoma	0.234	0.385	CbGbCtD
Ciclesonide—CYP2D6—Vemurafenib—melanoma	0.202	0.332	CbGbCtD
Ciclesonide—CYP3A4—Vemurafenib—melanoma	0.128	0.211	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—melanoma	0.0441	0.0724	CbGbCtD
Ciclesonide—Hyperadrenocorticism—Temozolomide—melanoma	0.0223	0.0753	CcSEcCtD
Ciclesonide—Impaired healing—Carmustine—melanoma	0.00826	0.0279	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00822	0.0277	CcSEcCtD
Ciclesonide—Oral candidiasis—Carmustine—melanoma	0.00563	0.019	CcSEcCtD
Ciclesonide—Oral candidiasis—Temozolomide—melanoma	0.00544	0.0183	CcSEcCtD
Ciclesonide—Pain in extremity—Vemurafenib—melanoma	0.00491	0.0165	CcSEcCtD
Ciclesonide—Ulcer—Bleomycin—melanoma	0.00433	0.0146	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.0042	0.0142	CcSEcCtD
Ciclesonide—Ulcer—Dactinomycin—melanoma	0.00404	0.0136	CcSEcCtD
Ciclesonide—Wheezing—Bleomycin—melanoma	0.00398	0.0134	CcSEcCtD
Ciclesonide—Infestation NOS—Vemurafenib—melanoma	0.00378	0.0127	CcSEcCtD
Ciclesonide—Infestation—Vemurafenib—melanoma	0.00378	0.0127	CcSEcCtD
Ciclesonide—Oral candidiasis—Docetaxel—melanoma	0.00362	0.0122	CcSEcCtD
Ciclesonide—Candida infection—Carmustine—melanoma	0.00341	0.0115	CcSEcCtD
Ciclesonide—Pharyngolaryngeal pain—Docetaxel—melanoma	0.0034	0.0115	CcSEcCtD
Ciclesonide—Laryngeal pain—Docetaxel—melanoma	0.00337	0.0114	CcSEcCtD
Ciclesonide—Candida infection—Temozolomide—melanoma	0.0033	0.0111	CcSEcCtD
Ciclesonide—Mediastinal disorder—Vemurafenib—melanoma	0.00306	0.0103	CcSEcCtD
Ciclesonide—Diabetes mellitus—Carmustine—melanoma	0.00298	0.0101	CcSEcCtD
Ciclesonide—Swelling—Carmustine—melanoma	0.00294	0.00992	CcSEcCtD
Ciclesonide—Ear pain—Temozolomide—melanoma	0.00294	0.00991	CcSEcCtD
Ciclesonide—Dysgeusia—Vemurafenib—melanoma	0.00289	0.00975	CcSEcCtD
Ciclesonide—Back pain—Vemurafenib—melanoma	0.00286	0.00964	CcSEcCtD
Ciclesonide—Rhinorrhoea—Docetaxel—melanoma	0.00284	0.00956	CcSEcCtD
Ciclesonide—Gastroenteritis—Temozolomide—melanoma	0.00283	0.00954	CcSEcCtD
Ciclesonide—Nasal congestion—Temozolomide—melanoma	0.00275	0.00928	CcSEcCtD
Ciclesonide—Chest discomfort—Docetaxel—melanoma	0.0026	0.00875	CcSEcCtD
Ciclesonide—Cough—Vemurafenib—melanoma	0.00258	0.00869	CcSEcCtD
Ciclesonide—Bronchospasm—Bleomycin—melanoma	0.00253	0.00852	CcSEcCtD
Ciclesonide—Oropharyngeal pain—Docetaxel—melanoma	0.00253	0.00852	CcSEcCtD
Ciclesonide—Arthralgia—Vemurafenib—melanoma	0.00252	0.00848	CcSEcCtD
Ciclesonide—Face oedema—Carmustine—melanoma	0.0025	0.00844	CcSEcCtD
Ciclesonide—Face oedema—Temozolomide—melanoma	0.00242	0.00816	CcSEcCtD
Ciclesonide—Infection—Vemurafenib—melanoma	0.0024	0.00808	CcSEcCtD
Ciclesonide—Pneumonia—Bleomycin—melanoma	0.0023	0.00777	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Temozolomide—melanoma	0.00221	0.00746	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0022	0.00741	CcSEcCtD
Ciclesonide—Candida infection—Docetaxel—melanoma	0.00219	0.00739	CcSEcCtD
Ciclesonide—Pneumonia—Dactinomycin—melanoma	0.00215	0.00724	CcSEcCtD
Ciclesonide—Bronchitis—Temozolomide—melanoma	0.00208	0.00703	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00208	0.00702	CcSEcCtD
Ciclesonide—Fatigue—Vemurafenib—melanoma	0.00208	0.00701	CcSEcCtD
Ciclesonide—Haemoglobin—Bleomycin—melanoma	0.00207	0.00697	CcSEcCtD
Ciclesonide—Haemorrhage—Bleomycin—melanoma	0.00206	0.00693	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Temozolomide—melanoma	0.00201	0.00679	CcSEcCtD
Ciclesonide—Pneumonia—Carmustine—melanoma	0.00201	0.00678	CcSEcCtD
Ciclesonide—Weight increased—Temozolomide—melanoma	0.00197	0.00665	CcSEcCtD
Ciclesonide—Urinary tract infection—Carmustine—melanoma	0.00194	0.00655	CcSEcCtD
Ciclesonide—Pneumonia—Temozolomide—melanoma	0.00194	0.00655	CcSEcCtD
Ciclesonide—Infestation NOS—Temozolomide—melanoma	0.00193	0.00651	CcSEcCtD
Ciclesonide—Infestation—Temozolomide—melanoma	0.00193	0.00651	CcSEcCtD
Ciclesonide—Pharyngitis—Dactinomycin—melanoma	0.0019	0.00642	CcSEcCtD
Ciclesonide—Swelling—Docetaxel—melanoma	0.00189	0.00637	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—APAF1—melanoma	0.00188	0.0199	CbGpPWpGaD
Ciclesonide—Urinary tract infection—Temozolomide—melanoma	0.00188	0.00633	CcSEcCtD
Ciclesonide—Sinusitis—Temozolomide—melanoma	0.00181	0.00611	CcSEcCtD
Ciclesonide—Haemoglobin—Carmustine—melanoma	0.0018	0.00608	CcSEcCtD
Ciclesonide—Haemorrhage—Carmustine—melanoma	0.00179	0.00605	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—EPHA2—melanoma	0.00178	0.0189	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—ERCC2—melanoma	0.00175	0.0185	CbGpPWpGaD
Ciclesonide—Haemoglobin—Temozolomide—melanoma	0.00174	0.00588	CcSEcCtD
Ciclesonide—Haemorrhage—Temozolomide—melanoma	0.00173	0.00585	CcSEcCtD
Ciclesonide—Asthenia—Vemurafenib—melanoma	0.00173	0.00583	CcSEcCtD
Ciclesonide—Pharyngitis—Temozolomide—melanoma	0.00172	0.0058	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SLC6A11—melanoma	0.00167	0.0177	CbGpPWpGaD
Ciclesonide—Pain in extremity—Docetaxel—melanoma	0.00167	0.00562	CcSEcCtD
Ciclesonide—Dizziness—Vemurafenib—melanoma	0.00159	0.00538	CcSEcCtD
Ciclesonide—Immune system disorder—Temozolomide—melanoma	0.00157	0.00528	CcSEcCtD
Ciclesonide—Mediastinal disorder—Temozolomide—melanoma	0.00156	0.00527	CcSEcCtD
Ciclesonide—Cough—Bleomycin—melanoma	0.00156	0.00527	CcSEcCtD
Ciclesonide—Chest pain—Bleomycin—melanoma	0.00152	0.00514	CcSEcCtD
Ciclesonide—Rash—Vemurafenib—melanoma	0.00152	0.00513	CcSEcCtD
Ciclesonide—Dermatitis—Vemurafenib—melanoma	0.00152	0.00512	CcSEcCtD
Ciclesonide—Back pain—Carmustine—melanoma	0.00151	0.0051	CcSEcCtD
Ciclesonide—Headache—Vemurafenib—melanoma	0.00151	0.00509	CcSEcCtD
Ciclesonide—Nasopharyngitis—Docetaxel—melanoma	0.00149	0.00503	CcSEcCtD
Ciclesonide—Dysgeusia—Temozolomide—melanoma	0.00148	0.00499	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Docetaxel—melanoma	0.00147	0.00496	CcSEcCtD
Ciclesonide—Back pain—Temozolomide—melanoma	0.00146	0.00492	CcSEcCtD
Ciclesonide—Infection—Bleomycin—melanoma	0.00145	0.00489	CcSEcCtD
Ciclesonide—Nausea—Vemurafenib—melanoma	0.00143	0.00483	CcSEcCtD
Ciclesonide—Bronchospasm—Docetaxel—melanoma	0.00142	0.00478	CcSEcCtD
Ciclesonide—Angioedema—Temozolomide—melanoma	0.00138	0.00465	CcSEcCtD
Ciclesonide—Infection—Dactinomycin—melanoma	0.00135	0.00456	CcSEcCtD
Ciclesonide—Hypertension—Carmustine—melanoma	0.00135	0.00455	CcSEcCtD
Ciclesonide—Palpitations—Temozolomide—melanoma	0.00133	0.0045	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00133	0.00449	CcSEcCtD
Ciclesonide—Chest pain—Carmustine—melanoma	0.00133	0.00448	CcSEcCtD
Ciclesonide—Cough—Temozolomide—melanoma	0.00132	0.00444	CcSEcCtD
Ciclesonide—Weight increased—Docetaxel—melanoma	0.00131	0.00442	CcSEcCtD
Ciclesonide—Hypertension—Temozolomide—melanoma	0.0013	0.0044	CcSEcCtD
Ciclesonide—Dyspnoea—Bleomycin—melanoma	0.0013	0.00439	CcSEcCtD
Ciclesonide—Pneumonia—Docetaxel—melanoma	0.00129	0.00436	CcSEcCtD
Ciclesonide—Arthralgia—Temozolomide—melanoma	0.00129	0.00433	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—melanoma	0.00128	0.00433	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—melanoma	0.00128	0.00433	CcSEcCtD
Ciclesonide—Infection—Carmustine—melanoma	0.00127	0.00427	CcSEcCtD
Ciclesonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—melanoma	0.00126	0.0134	CbGpPWpGaD
Ciclesonide—Dry mouth—Temozolomide—melanoma	0.00126	0.00424	CcSEcCtD
Ciclesonide—Conjunctivitis—Docetaxel—melanoma	0.00125	0.00421	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00124	0.00419	CcSEcCtD
Ciclesonide—Infection—Temozolomide—melanoma	0.00122	0.00413	CcSEcCtD
Ciclesonide—Epistaxis—Docetaxel—melanoma	0.00121	0.00409	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—ASIP—melanoma	0.00121	0.0128	CbGpPWpGaD
Ciclesonide—CYP2D6—Codeine and Morphine Metabolism—ABCB1—melanoma	0.0012	0.0127	CbGpPWpGaD
Ciclesonide—Fatigue—Dactinomycin—melanoma	0.00117	0.00396	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—MAP2—melanoma	0.00117	0.0124	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Carmustine—melanoma	0.00116	0.00392	CcSEcCtD
Ciclesonide—Urticaria—Bleomycin—melanoma	0.00116	0.00391	CcSEcCtD
Ciclesonide—Haemoglobin—Docetaxel—melanoma	0.00116	0.00391	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—melanoma	0.00116	0.0039	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—melanoma	0.00115	0.00389	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—melanoma	0.00114	0.00386	CcSEcCtD
Ciclesonide—Dyspnoea—Carmustine—melanoma	0.00114	0.00383	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00112	0.00379	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Carmustine—melanoma	0.0011	0.00371	CcSEcCtD
Ciclesonide—Dyspnoea—Temozolomide—melanoma	0.0011	0.0037	CcSEcCtD
Ciclesonide—Dyspepsia—Temozolomide—melanoma	0.00108	0.00366	CcSEcCtD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K2—melanoma	0.00107	0.0113	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Temozolomide—melanoma	0.00106	0.00359	CcSEcCtD
Ciclesonide—Fatigue—Temozolomide—melanoma	0.00106	0.00358	CcSEcCtD
Ciclesonide—Asthenia—Bleomycin—melanoma	0.00105	0.00353	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00104	0.0111	CbGpPWpGaD
Ciclesonide—Immune system disorder—Docetaxel—melanoma	0.00104	0.00351	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—melanoma	0.00104	0.0035	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—NODAL—melanoma	0.000991	0.0105	CbGpPWpGaD
Ciclesonide—Dysgeusia—Docetaxel—melanoma	0.000983	0.00332	CcSEcCtD
Ciclesonide—Urticaria—Temozolomide—melanoma	0.000979	0.0033	CcSEcCtD
Ciclesonide—Asthenia—Dactinomycin—melanoma	0.000978	0.0033	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—melanoma	0.000971	0.00327	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—E2F1—melanoma	0.000955	0.0101	CbGpPWpGaD
Ciclesonide—Rash—Bleomycin—melanoma	0.000921	0.00311	CcSEcCtD
Ciclesonide—Dermatitis—Bleomycin—melanoma	0.00092	0.0031	CcSEcCtD
Ciclesonide—Asthenia—Carmustine—melanoma	0.000915	0.00308	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—melanoma	0.000887	0.00299	CcSEcCtD
Ciclesonide—Asthenia—Temozolomide—melanoma	0.000884	0.00298	CcSEcCtD
Ciclesonide—CYP3A4—Liver X Receptor Pathway—FASN—melanoma	0.000877	0.00929	CbGpPWpGaD
Ciclesonide—Cough—Docetaxel—melanoma	0.000876	0.00295	CcSEcCtD
Ciclesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—melanoma	0.000869	0.0092	CbGpPWpGaD
Ciclesonide—Nausea—Bleomycin—melanoma	0.000868	0.00293	CcSEcCtD
Ciclesonide—Hypertension—Docetaxel—melanoma	0.000867	0.00292	CcSEcCtD
Ciclesonide—Rash—Dactinomycin—melanoma	0.000859	0.0029	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—melanoma	0.000855	0.00288	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—melanoma	0.000855	0.00288	CcSEcCtD
Ciclesonide—Dizziness—Carmustine—melanoma	0.000843	0.00284	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—melanoma	0.000836	0.00282	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—melanoma	0.000835	0.00884	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—CDK2—melanoma	0.000824	0.00872	CbGpPWpGaD
Ciclesonide—Dizziness—Temozolomide—melanoma	0.000815	0.00275	CcSEcCtD
Ciclesonide—Infection—Docetaxel—melanoma	0.000814	0.00274	CcSEcCtD
Ciclesonide—Nausea—Dactinomycin—melanoma	0.000809	0.00273	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—BCL2L11—melanoma	0.000806	0.00854	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—melanoma	0.000806	0.00853	CbGpPWpGaD
Ciclesonide—Rash—Carmustine—melanoma	0.000804	0.00271	CcSEcCtD
Ciclesonide—Dermatitis—Carmustine—melanoma	0.000803	0.00271	CcSEcCtD
Ciclesonide—Headache—Carmustine—melanoma	0.000799	0.00269	CcSEcCtD
Ciclesonide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—melanoma	0.000786	0.00833	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—ATM—melanoma	0.000782	0.00828	CbGpPWpGaD
Ciclesonide—Rash—Temozolomide—melanoma	0.000777	0.00262	CcSEcCtD
Ciclesonide—Dermatitis—Temozolomide—melanoma	0.000776	0.00262	CcSEcCtD
Ciclesonide—Headache—Temozolomide—melanoma	0.000772	0.0026	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SLC5A5—melanoma	0.000766	0.00811	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—melanoma	0.000759	0.00804	CbGpPWpGaD
Ciclesonide—Nausea—Carmustine—melanoma	0.000757	0.00255	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000747	0.00252	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—melanoma	0.000736	0.00779	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—NPPA—melanoma	0.000734	0.00777	CbGpPWpGaD
Ciclesonide—Nausea—Temozolomide—melanoma	0.000732	0.00247	CcSEcCtD
Ciclesonide—Dyspnoea—Docetaxel—melanoma	0.000731	0.00246	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—melanoma	0.000721	0.00243	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—melanoma	0.000708	0.00239	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—melanoma	0.000707	0.00238	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—VDR—melanoma	0.000682	0.00722	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—RB1—melanoma	0.000677	0.00717	CbGpPWpGaD
Ciclesonide—CYP2D6—Tamoxifen metabolism—CYP1B1—melanoma	0.000675	0.00715	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—ETS1—melanoma	0.000654	0.00693	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—melanoma	0.000625	0.00662	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—MAP2—melanoma	0.0006	0.00635	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—CDKN2A—melanoma	0.000595	0.0063	CbGpPWpGaD
Ciclesonide—Asthenia—Docetaxel—melanoma	0.000588	0.00198	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—HGF—melanoma	0.000567	0.006	CbGpPWpGaD
Ciclesonide—Dizziness—Docetaxel—melanoma	0.000542	0.00183	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—VDR—melanoma	0.000539	0.00571	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—CDKN1B—melanoma	0.000527	0.00558	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—CYP1B1—melanoma	0.000521	0.00552	CbGpPWpGaD
Ciclesonide—Rash—Docetaxel—melanoma	0.000517	0.00174	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—melanoma	0.000516	0.00174	CcSEcCtD
Ciclesonide—Headache—Docetaxel—melanoma	0.000513	0.00173	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TP73—melanoma	0.00051	0.0054	CbGpPWpGaD
Ciclesonide—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	0.000499	0.00529	CbGpPWpGaD
Ciclesonide—Nausea—Docetaxel—melanoma	0.000487	0.00164	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN1A—melanoma	0.000486	0.00515	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—melanoma	0.000485	0.00514	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—melanoma	0.000477	0.00506	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—melanoma	0.000477	0.00506	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—PPARG—melanoma	0.000475	0.00503	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—melanoma	0.000473	0.00501	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.000469	0.00496	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—melanoma	0.000461	0.00489	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—UGT2B10—melanoma	0.000447	0.00474	CbGpPWpGaD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	0.000441	0.00467	CbGpPWpGaD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.00043	0.00456	CbGpPWpGaD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000429	0.00455	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—EDN1—melanoma	0.000422	0.00447	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—HIF1A—melanoma	0.000416	0.0044	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—EDN1—melanoma	0.000411	0.00436	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL10—melanoma	0.000407	0.00431	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—MYC—melanoma	0.000403	0.00427	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CSF2—melanoma	0.000402	0.00426	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL4—melanoma	0.000396	0.00419	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—PRKCA—melanoma	0.000395	0.00418	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—melanoma	0.000391	0.00414	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.000382	0.00404	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.00038	0.00402	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—melanoma	0.000375	0.00398	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.000372	0.00394	CbGpPWpGaD
Ciclesonide—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000362	0.00384	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.000362	0.00383	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—HLA-A—melanoma	0.000358	0.0038	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—melanoma	0.000354	0.00375	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—melanoma	0.000349	0.00369	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000346	0.00367	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP1—melanoma	0.000346	0.00366	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—HIF1A—melanoma	0.000343	0.00363	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000342	0.00362	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—NOTCH1—melanoma	0.000316	0.00335	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.000315	0.00334	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—APC—melanoma	0.000309	0.00327	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.000305	0.00323	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.000302	0.0032	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.000297	0.00315	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000292	0.0031	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000291	0.00309	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000288	0.00305	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.000285	0.00302	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—AKR1B10—melanoma	0.000284	0.00301	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000281	0.00297	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.000277	0.00293	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—SOCS1—melanoma	0.000276	0.00293	CbGpPWpGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000259	0.00275	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000247	0.00262	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000247	0.00261	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	0.000245	0.0026	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—E2F1—melanoma	0.00024	0.00254	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IFNG—melanoma	0.000239	0.00253	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CLNS1A—melanoma	0.000238	0.00253	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000236	0.0025	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000236	0.0025	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000226	0.0024	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000223	0.00237	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	0.000222	0.00236	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—FAS—melanoma	0.000222	0.00235	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	0.000217	0.0023	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	0.000214	0.00227	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—melanoma	0.000213	0.00225	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	0.000211	0.00223	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	0.00021	0.00222	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	0.00021	0.00222	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—HIF1A—melanoma	0.000209	0.00221	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SKI—melanoma	0.000209	0.00221	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—melanoma	0.000207	0.00219	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	0.000205	0.00217	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—NFKB1—melanoma	0.000204	0.00216	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—melanoma	0.000201	0.00213	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PTEN—melanoma	0.0002	0.00212	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	0.000196	0.00208	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00019	0.00202	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000188	0.00199	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	0.000187	0.00198	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	0.000186	0.00197	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000183	0.00194	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000181	0.00191	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000178	0.00189	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARG—melanoma	0.000178	0.00188	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	0.000177	0.00187	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	0.000175	0.00186	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000172	0.00182	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—RB1—melanoma	0.00017	0.0018	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IGF1—melanoma	0.000169	0.00179	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.000167	0.00177	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—melanoma	0.000166	0.00176	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NPPA—melanoma	0.000163	0.00173	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000154	0.00164	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	0.000151	0.00159	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP17A1—melanoma	0.000149	0.00158	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000148	0.00157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	0.000147	0.00156	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	0.000143	0.00152	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000136	0.00145	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1B1—melanoma	0.000125	0.00133	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CTNNB1—melanoma	0.000125	0.00132	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—melanoma	0.000125	0.00132	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	0.000124	0.00131	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CDKN1A—melanoma	0.000122	0.00129	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	0.00012	0.00127	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000117	0.00124	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000112	0.00119	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.00011	0.00117	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	0.00011	0.00117	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—melanoma	0.000109	0.00115	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000108	0.00114	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000105	0.00111	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000103	0.00109	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPS3—melanoma	0.000102	0.00108	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000102	0.00108	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SNRPE—melanoma	0.0001	0.00106	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SKI—melanoma	0.0001	0.00106	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP17A1—melanoma	9.74e-05	0.00103	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	9.61e-05	0.00102	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	9.54e-05	0.00101	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	9.51e-05	0.00101	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—melanoma	9.43e-05	0.000999	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—VDR—melanoma	9.3e-05	0.000986	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACER3—melanoma	8.36e-05	0.000886	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1B1—melanoma	8.2e-05	0.000869	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	8.15e-05	0.000864	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	8.09e-05	0.000857	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NPPA—melanoma	7.86e-05	0.000833	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UGT2B10—melanoma	7.65e-05	0.00081	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—melanoma	7.61e-05	0.000806	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HS3ST5—melanoma	7.11e-05	0.000753	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	6.87e-05	0.000728	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	6.58e-05	0.000697	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARG—melanoma	6.49e-05	0.000687	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HDAC2—melanoma	5.75e-05	0.000609	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACER3—melanoma	5.47e-05	0.000579	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLCB4—melanoma	5.39e-05	0.000571	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC6A11—melanoma	5.07e-05	0.000537	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIP4K2A—melanoma	5.07e-05	0.000537	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UGT2B10—melanoma	5e-05	0.00053	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTAP—melanoma	4.93e-05	0.000522	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HS3ST5—melanoma	4.65e-05	0.000493	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CDKN2B—melanoma	4.59e-05	0.000487	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—VDR—melanoma	4.48e-05	0.000474	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PHGDH—melanoma	4.39e-05	0.000465	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LUM—melanoma	4.39e-05	0.000465	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HPSE—melanoma	4.31e-05	0.000456	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CUBN—melanoma	4.23e-05	0.000448	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PRKCA—melanoma	4.13e-05	0.000438	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ERCC2—melanoma	4.1e-05	0.000434	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SDHD—melanoma	4.08e-05	0.000433	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CSPG4—melanoma	4.08e-05	0.000433	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BSG—melanoma	4.08e-05	0.000433	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPAM—melanoma	3.96e-05	0.000419	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—melanoma	3.7e-05	0.000392	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLCB4—melanoma	3.52e-05	0.000373	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLA2G6—melanoma	3.36e-05	0.000356	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC6A11—melanoma	3.31e-05	0.000351	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIP4K2A—melanoma	3.31e-05	0.000351	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH1—melanoma	3.31e-05	0.00035	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTAP—melanoma	3.22e-05	0.000341	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARG—melanoma	3.12e-05	0.000331	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—VCAN—melanoma	3.02e-05	0.00032	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PHGDH—melanoma	2.87e-05	0.000304	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LUM—melanoma	2.87e-05	0.000304	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HPSE—melanoma	2.82e-05	0.000298	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CUBN—melanoma	2.76e-05	0.000293	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SDHD—melanoma	2.67e-05	0.000283	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CSPG4—melanoma	2.67e-05	0.000283	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BSG—melanoma	2.67e-05	0.000283	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPAM—melanoma	2.59e-05	0.000274	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP17A1—melanoma	2.55e-05	0.00027	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GNA11—melanoma	2.41e-05	0.000255	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FASN—melanoma	2.36e-05	0.00025	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A5—melanoma	2.32e-05	0.000245	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CD44—melanoma	2.24e-05	0.000237	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GNAQ—melanoma	2.24e-05	0.000237	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLA2G6—melanoma	2.2e-05	0.000233	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1B1—melanoma	2.15e-05	0.000227	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—VCAN—melanoma	1.98e-05	0.000209	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MAPK3—melanoma	1.83e-05	0.000194	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—melanoma	1.78e-05	0.000189	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCB1—melanoma	1.77e-05	0.000187	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP17A1—melanoma	1.67e-05	0.000177	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PRKCA—melanoma	1.63e-05	0.000172	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ERCC2—melanoma	1.61e-05	0.000171	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GNA11—melanoma	1.57e-05	0.000167	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FASN—melanoma	1.54e-05	0.000163	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A5—melanoma	1.51e-05	0.00016	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GNAQ—melanoma	1.46e-05	0.000155	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CD44—melanoma	1.46e-05	0.000155	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1B1—melanoma	1.4e-05	0.000149	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—melanoma	1.27e-05	0.000135	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—melanoma	1.23e-05	0.000131	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARG—melanoma	1.23e-05	0.00013	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCB1—melanoma	1.16e-05	0.000122	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CD—melanoma	1.12e-05	0.000119	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—melanoma	1.11e-05	0.000117	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PRKCA—melanoma	1.06e-05	0.000113	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ERCC2—melanoma	1.05e-05	0.000112	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CB—melanoma	9.76e-06	0.000103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—melanoma	9.67e-06	0.000102	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—melanoma	8.43e-06	8.93e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—melanoma	8.33e-06	8.82e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARG—melanoma	8.04e-06	8.51e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CD—melanoma	7.32e-06	7.75e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—melanoma	7.23e-06	7.65e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CB—melanoma	6.38e-06	6.76e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—melanoma	6.32e-06	6.7e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—melanoma	5.95e-06	6.3e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—melanoma	5.51e-06	5.84e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—melanoma	4.86e-06	5.15e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—melanoma	3.89e-06	4.12e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—melanoma	3.18e-06	3.37e-05	CbGpPWpGaD
